reviewTop 10% cited
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
Urology · 1998 · Vol. 52(4) · pp. 637–640
SUSAN D. SWEAT(Mayo Clinic)Anna Pacelli(Mayo Clinic)Gerald P. Murphy(Pacific Northwest Diabetes Research Institute)David G. Bostwick✉(Mayo Clinic)
Prostate Cancer Treatment and ResearchUrologic and reproductive health conditionsProstate Cancer Diagnosis and TreatmentMedicineLymph nodeProstate cancerImmunohistochemistryProstateAdenocarcinomaPathologyGlutamate carboxypeptidase IILymphRadical retropubic prostatectomy
MeSH terms
AdenocarcinomaAntigens, NeoplasmAntigens, SurfaceCarboxypeptidasesHumansLymphatic MetastasisMaleProstatic NeoplasmsGlutamate Carboxypeptidase II
Citations
598
FWCI
6.53
field-weighted impact
References
29
Percentile
97%
vs. same field & year
Citations per year
Cited by
Diagnostic Efficacy of <sup>68</sup> Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
The Journal of Urology · 2015 · 777 citations
Expression of Prostate‐Specific Membrane Antigen in Normal and Malignant Human Tissues
World Journal of Surgery · 2006 · 375 citations
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
Human Pathology · 2007 · 457 citations
References
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy
Urology · 1996 · 627 citations
Cancer statistics, 1998
CA A Cancer Journal for Clinicians · 1998 · 2,384 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.